Side-by-side comparison of AI visibility scores, market position, and capabilities
Columbus GA supplemental insurance (NYSE: AFL) at $19.13B 2024 revenue, $5.44B net income; largest US supplemental insurer and Japan's largest insurer (1-in-4 households), 16% dividend increase Q1 2025 competing with Unum and MetLife.
Aflac Incorporated is a Columbus, Georgia-based supplemental health and life insurance company — publicly traded on the New York Stock Exchange (NYSE: AFL) as an S&P 500 Financials component — providing voluntary, payroll-deducted supplemental insurance policies that pay cash benefits directly to policyholders when they experience a covered illness, injury, or medical event, operating in the United States and Japan through approximately 11,500 employees and 70,000+ US agents and brokers. Aflac is the largest supplemental insurance provider in the United States and the largest insurance company in Japan (where approximately 1 in 4 Japanese households holds an Aflac policy). In fiscal year 2024, Aflac reported full-year revenue of $19.13 billion and net income of $5.44 billion, with Q4 2024 revenues of $5.4 billion and net earnings of $1.9 billion ($3.42 diluted EPS) — and the company announced a 16% dividend increase for Q1 2025, reflecting the business's strong capital generation. CEO Dan Amos has led Aflac since 1990, building one of the most recognized insurance brands globally through the Aflac Duck mascot (introduced 2000) that made Aflac's name synonymous with voluntary supplemental insurance in the United States. Aflac Japan generates the majority of Aflac's earnings through cancer insurance, medical insurance, and income support policies sold through bank channel partnerships (Japan Post Bank, major regional banks) and traditional agents.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.